Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)
How Iran Nuke Deal Impacts U.S. and Global Economy
25:44 - With Obama securing enough Senate votes to support an historic accord, it looks like Iran is closer to emerging from some of the financial restrictions imposed to discourage it from developing nuclear weapons. Bloomberg's Phil Mattingly reports on "Bloomberg Markets." (Source: Bloomberg)
  • Is the High Cost of Live Sports at a Tipping Point?
  • Bloomberg Brief Weekly Video 09/03/15
  • Jaguar Is Slashing Prices on Two New Models